Literature DB >> 10231477

Characterisation and expression of the PKD-1 protein, polycystin, in renal and extrarenal tissues.

.   

Abstract

Studies of the nature and expression of the PKD-1 gene product, polycystin, have been complicated by duplication of the PKD-1 gene, the low expression of the PKD-1 gene in adult tissues and the lack of antibodies to epitopes in the duplicated region of polycystin. Using five monoclonal and polyclonal antibodies to epitopes encompassing the whole of the polycystin molecule, we have studied the biochemical and cellular expression of polycystin, and sought to identify homologues and alternative splice forms of polycystin. We find that polycystin exists as a 400-500 kDa protein in normal kidney and in a range of renal epithelial cell lines by immunoblotting, using antibodies to four different epitopes. No evidence of translated products from the genes (HG) homologous to PKD-1 nor any major splice forms of polycystin was found. In renal cells, polycystin could be detected as a cell surface protein but significant intracellular concentrations were also found by cellular fractionation and immunofluorescence. In normal and PKD-1 fetal tissues, immunoreactive polycystin was detected in many different cell types outside the kidney including vascular smooth muscle cells, endothelium, pancreatic, biliary and respiratory ductal epithelia, thyroidal epithelium, endocardium, myocardium, oocytes and Leydig cells. In the developing mouse kidney, polycystin expression is seen in all nephron segments but expression becomes restricted to mature distal tubules and collecting ducts in adult life. These observations clarify the nature of the PKD-1 protein, provide a molecular basis for understanding the systemic nature of PKD-1 and may explain the known phenotypic difference in the nature of renal cysts between 'early-onset' cases and typical adult-onset disease.

Entities:  

Year:  1999        PMID: 10231477     DOI: 10.1046/j.1523-1755.1999.00404.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

2.  Polycystin-1 is required for stereocilia structure but not for mechanotransduction in inner ear hair cells.

Authors:  Katherine A Steigelman; Andrea Lelli; Xudong Wu; Jiangang Gao; Susan Lin; Klaus Piontek; Claas Wodarczyk; Alessandra Boletta; Hyunho Kim; Feng Qian; Gregory Germino; Gwenaëlle S G Géléoc; Jeffrey R Holt; Jian Zuo
Journal:  J Neurosci       Date:  2011-08-24       Impact factor: 6.167

3.  Polycystin-1 but not polycystin-2 deficiency causes upregulation of the mTOR pathway and can be synergistically targeted with rapamycin and metformin.

Authors:  Djalila Mekahli; Jean-Paul Decuypere; Eva Sammels; Kirsten Welkenhuyzen; Joost Schoeber; Marie-Pierre Audrezet; Anniek Corvelyn; Georges Dechênes; Albert C M Ong; Martijn J Wilmer; Lambertus van den Heuvel; Geert Bultynck; Jan B Parys; Ludwig Missiaen; Elena Levtchenko; Humbert De Smedt
Journal:  Pflugers Arch       Date:  2013-11-06       Impact factor: 3.657

4.  Human-Specific Abnormal Alternative Splicing of Wild-Type PKD1 Induces Premature Termination of Polycystin-1.

Authors:  Wendy A Lea; Stephen C Parnell; Darren P Wallace; James P Calvet; Lesya V Zelenchuk; Nehemiah S Alvarez; Christopher J Ward
Journal:  J Am Soc Nephrol       Date:  2018-09-05       Impact factor: 10.121

5.  The mechanosensory role of primary cilia in vascular hypertension.

Authors:  Surya M Nauli; Xingjian Jin; Beerend P Hierck
Journal:  Int J Vasc Med       Date:  2011-06-16

6.  Analysis of the polycystin complex (PCC) in human urinary exosome-like vesicles (ELVs).

Authors:  Wendy A Lea; Kerri McGreal; Madhulika Sharma; Stephen C Parnell; Lesya Zelenchuk; M Cristine Charlesworth; Benjamin J Madden; Kenneth L Johnson; Daniel J McCormick; Marie C Hogan; Christopher J Ward
Journal:  Sci Rep       Date:  2020-01-30       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.